Recommendation for Transitioning from High-Dose Trazodone to Duloxetine for Depression
Yes, you should reduce trazodone to a low dose (50-100 mg) for sleep and start duloxetine (Cymbalta) for depression, as trazodone at 200 mg has insufficient evidence for treating depression and is not FDA-approved for this indication.
Rationale for This Approach
Trazodone's Limited Role in Depression Treatment
The most recent American Academy of Sleep Medicine guideline (2017) explicitly recommends against using trazodone as a treatment for depression 1. A single study of trazodone 50 mg showed no clinically significant improvements in depressive symptoms, and the evidence quality was only moderate 1. Importantly, trazodone is not FDA-approved for insomnia and its efficacy for depression is not well established 2.
Multiple clinical practice guidelines consistently place trazodone as a third-line option for insomnia—only after benzodiazepine receptor agonists fail and specifically when treating comorbid depression/anxiety 2. The 2020 VA/DoD guideline advises against trazodone for chronic insomnia due to low-quality evidence and adverse effects outweighing benefits 3.
Duloxetine as First-Line for Depression
Duloxetine is a well-established first-line treatment for major depressive disorder 4, 5. It has shown consistent efficacy in treating depression with a straightforward dosing regimen 4. The FDA label confirms duloxetine's approval for major depressive disorder 6.
Key dosing strategy: Start duloxetine at 30 mg once daily for 1 week, then increase to 60 mg once daily 4. This gradual titration reduces nausea, the most common side effect 4. Research confirms that lower starting doses with slower titration significantly improve tolerability—discontinuation rates were only 3.6% with gradual titration versus 15% with rapid titration 7.
Specific Implementation Algorithm
Step 1: Initiate Duloxetine
- Start duloxetine 30 mg once daily in the morning
- After 7 days, increase to 60 mg once daily
- Monitor for nausea (most common side effect), which typically resolves after the first week 4
- Screen for bipolar disorder history before starting (detailed psychiatric and family history of mania, bipolar disorder, suicide) 6
Step 2: Reduce Trazodone Simultaneously
- Reduce trazodone from 200 mg to 50-100 mg at bedtime for sleep only
- This lower dose range is what's actually studied for insomnia 1
- Do not abruptly discontinue—taper gradually to avoid withdrawal symptoms 2
- The 2008 guideline notes "moderate efficacy for trazodone in improving sleep quality and/or duration" at these lower doses 2
Step 3: Monitor Specific Outcomes
- For depression: Assess mood, energy, concentration at 2-4 weeks; full therapeutic trial requires 4-8 weeks 4
- For sleep: Evaluate sleep quality, latency, and total sleep time weekly
- For safety: Check blood pressure before starting duloxetine and periodically thereafter 6; monitor liver function if risk factors present 6
Critical Safety Considerations
Duloxetine-Specific Warnings
- Hepatotoxicity: Avoid in patients with substantial alcohol use or chronic liver disease 6
- Blood pressure: Can increase systolic BP by 0.5 mmHg and diastolic by 0.8 mmHg 6
- Orthostatic hypotension: Risk increases when combined with antihypertensives or CYP1A2 inhibitors 6
- Bleeding risk: Use caution with NSAIDs, aspirin, or anticoagulants 6
Trazodone at Lower Doses
- At 50 mg, trazodone showed headache (30%) and somnolence (23%) as main side effects 1
- Monitor for daytime sedation, especially when combined with duloxetine 2
- Avoid in patients with cardiac conduction abnormalities 8
Drug Interaction Alert
Recent research shows that duloxetine significantly affects trazodone concentrations 9. When these medications are combined, trazodone levels may increase, necessitating closer monitoring for excessive sedation or other adverse effects. This supports using the lowest effective trazodone dose (50 mg) when combining with duloxetine.
Why Not Continue High-Dose Trazodone?
The evidence is clear: 200 mg trazodone for depression lacks supporting data. The 2017 AASM guideline found that even 50 mg trazodone failed to produce clinically significant improvements in any sleep or mood outcome variables 1. Higher doses simply increase side effect burden without proven benefit for depression 3, 10.
Alternative Consideration
If insomnia persists despite low-dose trazodone, consider first-line insomnia treatments such as short-intermediate acting benzodiazepine receptor agonists (zolpidem, eszopiclone) or cognitive behavioral therapy for insomnia (CBT-I), which has the strongest evidence base 2. The 2008 guideline notes that combining a benzodiazepine receptor agonist with a sedating antidepressant is supported by "a wealth of clinical experience" 2.
Common Pitfall to Avoid
Do not maintain trazodone at 200 mg while adding duloxetine. This exposes you to: